Need a specific person's email?
Browse Geneos Therapeutics's employee directory (about 12 employees) and reveal verified emails free.
Geneos Therapeutics's most common email format is Last@geneostx.com (ex. Doe@geneostx.com), used for 65% of geneostx.com addresses. Geneos Therapeutics uses 3 email patterns.
| Format | Example | Share of geneostx.com |
|---|---|---|
| Last@geneostx.comMost common | Doe@geneostx.com | |
| FLast@geneostx.com | JDoe@geneostx.com | |
| First-Last@geneostx.com | John-Doe@geneostx.com |
Browse Geneos Therapeutics's employee directory (about 12 employees) and reveal verified emails free.
Biotechnology ResearchPennsylvania, United States11-50 Employees
Geneos Therapeutics is an early-stage biotechnology company based in Plymouth Meeting, Pennsylvania, focused on developing personalized cancer vaccines that aim to mobilize the body's immune response against tumors. Its GT-EPIC platform helps identify tumor neoantigen targets and supports the end-to-end development of personalized, neoantigen-directed immunotherapies. The company operates within the biotechnology research field, pursuing tumor neoantigen-targeted immunotherapies for cancer. In recent developments, Geneos Therapeutics reported updated data from its GT-30 program in a Phase 1b/2a trial for second-line advanced hepatocellular carcinoma. The organization is small to mid-sized, reflecting the scale typical of early-phase biotech firms.
Most common format
Last@geneostx.com
Example: Doe@geneostx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.